Shiota Tomoyuki, Okame Michio, Takanashi Sayaka, Khamrin Pattara, Takagi Makiko, Satou Kenji, Masuoka Yuichi, Yagyu Fumihiro, Shimizu Yuko, Kohno Hideki, Mizuguchi Masashi, Okitsu Shoko, Ushijima Hiroshi
Department of Developmental Medical Sciences, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Tokyo, Japan.
J Virol. 2007 Nov;81(22):12298-306. doi: 10.1128/JVI.00891-07. Epub 2007 Sep 12.
Norovirus, which belongs to the family Caliciviridae, is one of the major causes of nonbacterial acute gastroenteritis in the world. The main human noroviruses are of genogroup I (GI) and genogroup II (GII), which were subdivided further into at least 15 and 18 genotypes (GI/1 to GI/15 and GII/1 to GII/18), respectively. The development of immunological diagnosis for norovirus had been hindered by the antigen specificity of the polyclonal antibody. Therefore, several laboratories have produced broadly reactive monoclonal antibodies, which recognize the linear GI and GII cross-reactive epitopes or the conformational GI-specific epitope. In this study, we characterized the novel monoclonal antibody 14-1 (MAb14-1) for further development of the rapid immunochromatography test. Our results demonstrated that MAb14-1 could recognize 15 recombinant virus-like particles (GI/1, 4, 8, and 11 and GII/1 to 7 and 12 to 15) and showed weak affinity to the virus-like particle of GI/3. This recognition range is the broadest of the existing monoclonal antibodies. The epitope for MAb14-1 was identified by fragment, sequence, structural, and mutational analyses. Both terminal antigenic regions (amino acid positions 418 to 426 and 526 to 534) on the C-terminal P1 domain formed the conformational epitope and were in the proximity of the insertion region (positions 427 to 525). These regions contained six amino acids responsible for antigenicity that were conserved among genogroup(s), genus, and Caliciviridae. This epitope mapping explained the broad reactivity and different titers among GI and GII. To our knowledge, we are the first group to identify the GI and GII cross-reactive monoclonal antibody, which recognizes the novel conformational epitope. From these data, MAb14-1 could be used further to develop immunochromatography.
诺如病毒属于杯状病毒科,是全球非细菌性急性肠胃炎的主要病因之一。主要的人类诺如病毒分为基因组I(GI)和基因组II(GII),它们又分别进一步细分为至少15种和18种基因型(GI/1至GI/15以及GII/1至GII/18)。诺如病毒免疫诊断的发展一直受到多克隆抗体抗原特异性的阻碍。因此,几个实验室已经制备了具有广泛反应性的单克隆抗体,这些抗体能够识别线性的GI和GII交叉反应表位或构象性的GI特异性表位。在本研究中,我们对新型单克隆抗体14-1(MAb14-1)进行了特性分析,以进一步开发快速免疫层析检测方法。我们的结果表明,MAb14-1能够识别15种重组病毒样颗粒(GI/1、4、8和11以及GII/1至7和12至15),并且对GI/3的病毒样颗粒表现出较弱的亲和力。这种识别范围是现有单克隆抗体中最广的。通过片段、序列、结构和突变分析确定了MAb14-1的表位。C末端P1结构域上的两个末端抗原区域(氨基酸位置418至426和526至534)形成了构象表位,并且靠近插入区域(位置427至525)。这些区域包含六个负责抗原性的氨基酸,它们在基因组、属和杯状病毒科中是保守的。这种表位图谱解释了GI和GII之间广泛的反应性和不同的效价。据我们所知,我们是第一个鉴定出识别新型构象表位的GI和GII交叉反应单克隆抗体的团队。基于这些数据,可以进一步利用MAb14-1开发免疫层析检测方法。